Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New ablation technique shows promise in Long-Term AFib control

NCT ID NCT06526546

Disease control Sponsor: Boston Scientific Corporation Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study followed 364 people with paroxysmal atrial fibrillation (a type of irregular heartbeat) who had already received ablation treatment in a previous trial. Researchers compared a newer pulsed field ablation system with traditional thermal ablation to see how well each method prevented the condition from getting worse over several years. The goal was to understand which approach offers better long-term control of heart rhythm problems.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

364 people

The number who actually took part.

Started

Oct 2024

Finished

Dec 2025

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Study eligibility criteria are defined below. Subjects who became deceased after completion of the ADVENT Trial will remain eligible for chart review data upon consent of a legally authorized representative (LAR). Subjects unable to complete the 7-day Holter monitor may consent to participate in the chart review portion only.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Subjects who meet all of the following criteria may be given consideration for inclusion in this clinical investigation. * Subjects who were enrolled, randomized and treated for paroxysmal atrial fibrillation, classified as Modified Intention-to-Treat subjects, and completed the 12-Month Follow-Up in the FARAPULSE ADVENT Trial (CIP CS0934; NCT04612244). * Subjects or legally authorized representatives who are willing and capable of providing informed consent. * Subjects who are willing to comply with the protocol requirements. Exclusion Criteria: * There are no exclusion criteria for this study.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Paroxysmal atrial fibrillation are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

atrial fibrillation atrial flutter paroxysmal atrial fibrillation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Paroxysmal atrial fibrillation

Contacts and locations

Locations

  • Banner University Medical Center Phoenix

    Phoenix, Arizona, 85006, United States

  • Beth Israel Deaconess Medical Center

    Boston, Massachusetts, 02215, United States

  • Doylestown Hospital

    Doylestown, Pennsylvania, 18901, United States

  • Emory University Hospital

    Atlanta, Georgia, 30322, United States

  • Grandview Medical Center

    Birmingham, Alabama, 35243, United States

  • Johns Hopkins Hospital

    Baltimore, Maryland, 21287, United States

  • Massachusetts General Hospital (MGH)

    Boston, Massachusetts, 02114, United States

  • Medical University of South Carolina

    Charleston, South Carolina, 29425, United States

  • Mills Peninsula Health Services

    Burlingame, California, 94010, United States

  • Mount Sinai, Icahn School of Medicine

    New York, New York, 10029, United States

  • Nebraska Methodist Hospital

    Omaha, Nebraska, 68114, United States

  • Northwell Health

    New York, New York, 10075, United States

  • Pinnacle Health at Harrisburg Hospital

    Wormleysburg, Pennsylvania, 17043, United States

  • Presbyterian University of Pennsylvania Medical Center

    Philadelphia, Pennsylvania, 19104, United States

  • Providence St. Vincent Medical Center

    Portland, Oregon, 97225, United States

  • Scripps Memorial Hospital

    La Jolla, California, 92037, United States

  • St. Luke's Hospital of Kansas City

    Kansas City, Missouri, 64111, United States

  • St. Lukes Idaho Cardiology Associates

    Boise, Idaho, 83702, United States

  • St. Thomas Research Institute, LLC

    Nashville, Tennessee, 37205, United States

  • Texas Cardiac Arrhythmia Research

    Austin, Texas, 78705, United States

  • Trident Medical Center

    Charleston, South Carolina, 29406, United States

  • University of California, San Francisco

    San Francisco, California, 94143-0628, United States

  • Vanderbilt University Medical Center

    Nashville, Tennessee, 37232, United States

  • Virginia Commonwealth University Health System

    Richmond, Virginia, 23219, United States

  • Washington Hospital Center

    Washington D.C., District of Columbia, 20010-2975, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.